tiprankstipranks
Advertisement
Advertisement

CVKD Stock Latest News

Regulatory Clarity and De-Risked Phase 3 Plan Support Cadrenal Buy Rating, $13 Target Unchanged
RatingsRegulatory Clarity and De-Risked Phase 3 Plan Support Cadrenal Buy Rating, $13 Target Unchanged
21h ago
CVKD
Cadrenal Therapeutics advances CAD-1005 Phase 3 pathway
PremiumCompany Announcements
Cadrenal Therapeutics advances CAD-1005 Phase 3 pathway
2d ago
8K
CVKD
Cadrenal Therapeutics gets feedback from CAD-1005 Type D Meeting with FDA
PremiumThe Fly
Cadrenal Therapeutics gets feedback from CAD-1005 Type D Meeting with FDA
2d ago
CVKD
Cadrenal Maintained at Buy as Partnership-Focused Strategy Supports Unchanged $13 Price Target
PremiumRatings
Cadrenal Maintained at Buy as Partnership-Focused Strategy Supports Unchanged $13 Price Target
19d ago
CVKD
Cadrenal Therapeutics Launches Cardiac Acute Care Franchise Strategy
PremiumCompany Announcements
Cadrenal Therapeutics Launches Cardiac Acute Care Franchise Strategy
1M ago
8K
CVKD
Cadrenal Therapeutics Announces Chief Medical Officer Transition
PremiumCompany AnnouncementsCadrenal Therapeutics Announces Chief Medical Officer Transition
2M ago
8K
CVKD
Cadrenal Therapeutics files to sell 2.94M shares of common stock for holders
Premium
The Fly
Cadrenal Therapeutics files to sell 2.94M shares of common stock for holders
2M ago
CVKD
Cadrenal Therapeutics announces clinical data from CAD-1005 study
Premium
The Fly
Cadrenal Therapeutics announces clinical data from CAD-1005 study
2M ago
CVKD
Cadrenal Therapeutics Announces Chief Medical Officer Resignation
PremiumCompany Announcements
Cadrenal Therapeutics Announces Chief Medical Officer Resignation
2M ago
8K
CVKD
Cadrenal Therapeutics Secures Private Placement to Extend Runway
PremiumCompany Announcements
Cadrenal Therapeutics Secures Private Placement to Extend Runway
2M ago
8K
CVKD
Cadrenal Names Interim CFO, Realigns Board Structure
PremiumCompany Announcements
Cadrenal Names Interim CFO, Realigns Board Structure
2M ago
8K
CVKD
Cadrenal Pursues Rare Pediatric Designation for Tecarfarin
PremiumCompany Announcements
Cadrenal Pursues Rare Pediatric Designation for Tecarfarin
3M ago
8K
CVKD
Cadrenal Therapeutics to file for FDA RPDD for tecarfarin in Kawasaki Disease
PremiumThe FlyCadrenal Therapeutics to file for FDA RPDD for tecarfarin in Kawasaki Disease
3M ago
CVKD
Cadrenal Therapeutics to initiate CAD-1005 trial
Premium
The Fly
Cadrenal Therapeutics to initiate CAD-1005 trial
3M ago
CVKD
Cadrenal Therapeutics Announces CFO Transition and Interim Appointment
Premium
Company Announcements
Cadrenal Therapeutics Announces CFO Transition and Interim Appointment
3M ago
8K
CVKD
Cadrenal Therapeutics completes CAD-1005 End-of-Phase 2 meeting with FDA
PremiumThe Fly
Cadrenal Therapeutics completes CAD-1005 End-of-Phase 2 meeting with FDA
4M ago
CVKD
Cadrenal Advances CAD-1005 Into FDA-Guided Phase 3 Trial
PremiumCompany Announcements
Cadrenal Advances CAD-1005 Into FDA-Guided Phase 3 Trial
4M ago
8K
CVKD
Cadrenal Therapeutics files to sell 1.18M shares of common stock for holders
PremiumThe Fly
Cadrenal Therapeutics files to sell 1.18M shares of common stock for holders
4M ago
CVKD
Cadrenal Therapeutics price target lowered to $13 from $32 at H.C. Wainwright
PremiumThe Fly
Cadrenal Therapeutics price target lowered to $13 from $32 at H.C. Wainwright
5M ago
CVKD
Cadrenal Therapeutics Inc trading halted, volatility trading pause
PremiumThe FlyCadrenal Therapeutics Inc trading halted, volatility trading pause
5M ago
CVKD
Cadrenal Therapeutics Inc trading resumes
Premium
The Fly
Cadrenal Therapeutics Inc trading resumes
5M ago
CVKD
Cadrenal Therapeutics Enters Warrant Inducement Financing Agreement
Premium
Company Announcements
Cadrenal Therapeutics Enters Warrant Inducement Financing Agreement
5M ago
8K
CVKD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >